RAVITHEJ SINGH ET AL.
7
biofilm-embedded staphylococcus cells. BioMed Research Interna-
tional, 2015, 890968.
thankful to CSIR, New Delhi, India; VCT, SH, AU and PK are grateful
to UGC, India for the financial support. SR is thankful to ICMR,
New Delhi, India for research fellowship. CSIR-CDRI communication
number: 9555.
Kiran, M. D., Adikesavan, N. V., Cirioni, O., Giacometti, A., Silvestri, C.,
Scalise, G., … Balaban, N. (2008). Discovery of a quorum-sensing inhibi-
tor of drug-resistant staphylococcal infections by structure-based vir-
tual screening. Molecular Pharmacology, 73(5), 1578–1586.
Lebeaux, D., Chauhan, A., Rendueles, O., & Beloin, C. (2013). From in vitro
to in vivo models of bacterial biofilm-related infections. Pathogens,
2(2), 288–356.
Lebeaux, D., Ghigo, J. M., & Beloin, C. (2014). Biofilm-related infections:
Bridging the gap between clinical management and fundamental
aspects of recalcitrance toward antibiotics. Microbiology and Molecular
Biology Reviews, 78(3), 510–543.
Mann, E. E., & Wozniak, D. J. (2012). Pseudomonas biofilm matrix compo-
sition and niche biology. FEMS Microbiology Reviews, 36(4), 893–916.
Martins, P. G., Mori, M., Chiaradia-Delatorre, L. D., Menegatti, A. C.,
Mascarello, A., Botta, B., … Terenzi, H. (2015). Exploring Oxidovanadium(IV)
complexes as YopH inhibitors: Mechanism of action and modeling studies.
ACS Medicinal Chemistry Letters, 6(10), 1035–1040.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
ORCID
L Ravithej Singh
Vikash C. Tripathi
Mukesh Pasupuleti
McElroy, K. E., Hui, J. G., Woo, J. K., Luk, A. W., Webb, J. S., Kjelleberg, S.,
…
Thomas, T. (2014). Strain-specific parallel evolution drives
REFERENCES
short-term diversification during Pseudomonas aeruginosa biofilm for-
mation. Proceedings of the National Academy of Sciences of the United
States of America, 111(14), E1419–E1427.
Al-Amiery, A. A., Al-Majedy, Y. K., Abdulreazak, H., & Abood, H. (2011). Syn-
thesis, characterization, theoretical crystal structure, and antibacterial
activities of some transition metal complexes of the Thiosemicarbazone
(Z)-2-(pyrrolidin-2-ylidene)hydrazinecarbothioamide. Bioinorganic Chemis-
try and Applications, 483101(10), 24.
Antoniani, D., Bocci, P., Maciag, A., Raffaelli, N., & Landini, P. (2010). Moni-
toring of diguanylate cyclase activity and of cyclic-di-GMP biosyn-
thesis by whole-cell assays suitable for high-throughput screening
of biofilm inhibitors. Applied Microbiology and Biotechnology, 85(4),
1095–1104.
Balamurugan, P., Hema, M., Kaur, G., Sridharan, V., Prabu, P. C.,
Sumana, M. N., & Princy, S. A. (2015). Development of a biofilm inhibi-
tor molecule against multidrug resistant Staphylococcus aureus associ-
ated with gestational urinary tract infections. Frontiers in Microbiology,
Blosser, R. S., & Gray, K. M. (2000). Extraction of violacein from Chromo-
bacterium violaceum provides a new quantitative bioassay for N-acyl
homoserine lactone autoinducers. Journal of Microbiological Methods,
40(1), 47–55.
Mdluli, K., Kaneko, T., & Upton, A. (2015). The tuberculosis drug discovery
and development pipeline and emerging drug targets. Cold Spring Har-
Moffat, J. G., Rudolph, J., & Bailey, D. (2014). Phenotypic screening in can-
cer drug discovery—past, present and future. Nature reviews. Drug dis-
covery, 13(8), 588–602.
Moradali, M. F., Ghods, S., & Rehm, B. H. (2017). Pseudomonas aeruginosa
lifestyle: A paradigm for adaptation, survival, and persistence. Frontiers
in Cellular and Infection Microbiology, 7, 39.
Morita, Y., Tomida, J., & Kawamura, Y. (2012). Primary mechanisms medi-
ating aminoglycoside resistance in the multidrug-resistant Pseudomo-
nas aeruginosa clinical isolate PA7. Microbiology, 158(4), 1071–1083.
Nalca, Y., Jansch, L., Bredenbruch, F., Geffers, R., Buer, J., & Haussler, S.
(2006). Quorum-sensing antagonistic activities of azithromycin in Pseu-
domonas aeruginosa PAO1: A global approach. Antimicrobial Agents and
Chemotherapy, 50(5), 1680–1688.
Brackman, G.,
& Coenye, T. (2015). Quorum sensing inhibitors as
O'Toole, G. A., & Kolter, R. (1998). Initiation of biofilm formation in Pseudo-
monas fluorescens WCS365 proceeds via multiple, convergent signal-
anti-biofilm agents. Current Pharmaceutical Design, 21(1), 5–11.
Butler, M. S., Fontaine, F., & Cooper, M. A. (2014). Natural product librar-
ies: Assembly, maintenance, and screening. Planta Medica, 80(14),
1161–1170.
Chua, S. L., Sivakumar, K., Rybtke, M., Yuan, M., Andersen, J. B.,
Nielsen, T. E., … Yang, L. (2015). C-di-GMP regulates Pseudomonas aer-
uginosa stress response to tellurite during both planktonic and biofilm
modes of growth. Scientific Reports, 5, 10052.
ling pathways:
A genetic analysis. Molecular Microbiology, 28(3),
449–461.
Pahontu, E., Fala, V., Gulea, A., Poirier, D., Tapcov, V., & Rosu, T. (2013).
Synthesis and characterization of some new cu(II), Ni(II) and
Zn(II) complexes with salicylidene thiosemicarbazones: Antibacterial,
antifungal and in vitro antileukemia activity. Molecules, 18(8),
8812–8836.
Dandapani, S., Rosse, G., Southall, N., Salvino, J. M., & Thomas, C. J. (2012).
Selecting, acquiring, and using small molecule libraries for high-throughput
screening. Current protocols in chemical biology, 4(3), 177–191.
Das, T., Kutty, S. K., Tavallaie, R., Ibugo, A. I., Panchompoo, J., Sehar, S., …
Manefield, M. (2015). Phenazine virulence factor binding to extracellu-
lar DNA is important for Pseudomonas aeruginosa biofilm formation.
Scientific Reports, 5, 8398.
Das, T., & Manefield, M. (2012). Pyocyanin promotes extracellular DNA
release in Pseudomonas aeruginosa. PLoS One, 7(10), e46718.
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003).
Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeru-
ginosa PAO1. Antimicrobial Agents and Chemotherapy, 47(3), 972–978.
Everett, J. R. (2015). Academic drug discovery: Current status and pros-
pects. Expert Opinion on Drug Discovery, 10(9), 937–944.
Hentzer, M., Riedel, K., Rasmussen, T. B., Heydorn, A., Andersen, J. B.,
Parsek, M. R., … Givskov, M. (2002). Inhibition of quorum sensing in
Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone
compound. Microbiology, 148(Pt 1), 87–102.
Rasmussen, T. B., Bjarnsholt, T., Skindersoe, M. E., Hentzer, M.,
Kristoffersen, P., Kote, M.,
… Givskov, M. (2005). Screening for
quorum-sensing inhibitors (QSI) by use of a novel genetic system, the
QSI selector. Journal of Bacteriology, 187(5), 1799–1814.
Rasmussen, T. B., Skindersoe, M. E., Bjarnsholt, T., Phipps, R. K.,
Christensen, K. B., Jensen, P. O., … Givskov, M. (2005). Identity and
effects of quorum-sensing inhibitors produced by Penicillium species.
Microbiology, 151(Pt 5), 1325–1340.
Sambanthamoorthy, K., Gokhale, A. A., Lao, W., Parashar, V.,
Neiditch, M. B., Semmelhack, M. F., … Waters, C. M. (2011). Identifica-
tion of a novel benzimidazole that inhibits bacterial biofilm formation
in a broad-spectrum manner. Antimicrobial Agents and Chemotherapy,
55(9), 4369–4378.
Shrestha, L., Kayama, S., Sasaki, M., Kato, F., Hisatsune, J., Tsuruda, K., …
Sugai, M. (2016). Inhibitory effects of antibiofilm compound 1 against
Staphylococcus aureus biofilms. Microbiology and Immunology, 60(3),
148–159.
Siddiqui, N., Akhtar, M. J., Yar, M. S., Ahuja, P., Ahsan, W., & Ahmed, S. (2014).
Substituted phenyl containing 1, 3, 4-oxadiazole-2-yl-but-2-enamides: Syn-
thesis and preliminary evaluation as promising anticonvulsants. Medicinal
Chemistry Research, 23(11), 4915–4925.
Kayumov, A. R., Nureeva, A. A., Trizna, E. Y., Gazizova, G. R.,
Bogachev, M. I., Shtyrlin, N. V., … Shtyrlin, Y. G. (2015). New deriva-
tives of pyridoxine exhibit high antibacterial activity against